Skip to content

Treatment of Irritable Bowel Syndrome (IBS) by a plant based Ayurvedic formulation

Ayurvedic formulation developed for the Prevention and management of Irritable Bowel Syndrome (IBS)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2015/05/005791
Enrollment
1000
Registered
2015-05-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Irritable Bowel Syndrome (IBS)

Interventions

Intervention1: Test formulation treatment 500mg twice per day for a period of 6months: The standard extracts prepared out of three Ayurvedic plant candidates like Babul (Acacia arabica), Jatamansi (Na

Sponsors

Adesh University
Lead Sponsor
Dr H S Gill
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Rome-III diagnostic criteria prescribed for IBS Recurrent abdominal pain or discomfort at least 3 days per month in the last 3 months associated with changes in frequency of stool. Onset associated with changes in appearance (form) of stool. Improvement with defecation.

Exclusion criteria

Exclusion criteria: Any gross Gastointestinal pathology Suffering from any chronic neuroendocrine or metabolic disorders.

Design outcomes

Primary

MeasureTime frame
A good number of patients reported improvement in recurrent abdominal pain, clear motion with no bowel movement including changes in stool form gradually after treatment with test formulation. Further, improvement was also noticed in depression score, sleep pattern of IBS patients. The chronic constipation also improved and patients reported feeling of well being and elevated mood and better mental performance.Timepoint: Gradual improvement (1 month to 6 months)

Secondary

MeasureTime frame
Improvement in body weight and appetite was noticed.Timepoint: Gradual improvement (1 month to 6 months)

Countries

India

Contacts

Public ContactDr Aiman Shah

Adesh Institute of Medical Sciences and Research

gpdubey13@gmail.com9450963942

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026